The new codes are for describing the infusion of tixagevimab and cilgavimab monoclonal antibody (code XW023X7), and the infusion of other new technology monoclonal antibody (code XW023Y7).
Why ICD-10 codes are important
The ICD-10-CM is a catalog of diagnosis codes used by medical professionals for medical coding and reporting in health care settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates.
ICD-10 code D69. 6 for Thrombocytopenia, unspecified is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
ICD-10 | Thrombocytopenia, unspecified (D69. 6)
6: Thrombocytopenia, unspecified.
Gestational thrombocytopenia (GT) is a benign condition with moderate thrombocytopenia (platelet count of 130-150.000/ìL) in most of the cases (4). Platelet values below 50.000/ìL in a pregnant woman exclude GT and require the search of another etiology. Gestational thrombocytopenia is a diagnosis of exclusion.
The ITP Syndrome ITP is an autoimmune bleeding disorder caused by various etiologies, which is characterized by increased platelet destruction and impaired production, resulting in a decreased platelet count. Primary ITP is idiopathic, whereas secondary ITP is linked to an underlying condition (1).
Z86. 2 - Personal history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | ICD-10-CM.
ICD-10 | Fever, unspecified (R50. 9)
Thrombocythemia and thrombocytosis are conditions that occur when your blood has a higher-than-normal platelet count. Platelets are tiny blood cells. They are made in your bone marrow along with other kinds of blood cells.
What causes thrombocytopenia?Alcohol use disorder and alcoholism.Autoimmune disease which causes ITP. ... Bone marrow diseases, including aplastic anemia, leukemia, certain lymphomas and myelodysplastic syndromes.Cancer treatments like chemotherapy and radiation therapy.More items...•
Gestational thrombocytopenia (defined as a mild thrombocytopenia, occurring during the 3 rd trimester with spontaneous resolution postpartum and no neonatal thrombocytopenia) is the most common cause of thrombocytopenia during pregnancy but a low platelet can also be associated with several diseases, either pregnancy ...
The diagnosis of GT is made by the presence of a decreased platelet count during pregnancy and should be considered a diagnosis of exclusion.
It's normal for your platelet count to dip by a few thousand during pregnancy, due in part to hemodilution: the body makes more plasma during pregnancy, so the total number of platelets per volume of blood will be lower.
Clinical Information. A condition in which there is a lower-than-normal number of platelets in the blood. It may result in easy bruising and excessive bleeding from wounds or bleeding in mucous membranes and other tissues.
A decrease in the number of platelets in the blood that may result in easy bruising and excessive bleeding from wound s or bleeding in mucous membranes and other tissues. A finding based on laboratory test results that indicate a decrease in number of platelets in a blood specimen. A subnormal level of blood platelets.
Pseudothrombocytopenia resulting from clumping of platelets collected in EDTA anticoagulant can also be identified by examining the blood film, and can be confirmed by re-collecting a specimen in citrateanticoagulant in which clumping will not occur.
Pseudothrombocytopenia is caused by various etiologies, including giant platelets, anticoagulant-induced pseudothrombocytopenia, platelet satellitism, and cold agglutinin-induced platelet agglutination. Pseudothrombocytopenia may occur with giant platelets. Due to their large size, the giant platelets are excluded from electronic platelet counting, causing pseudothrombocytopenia. This scenario is of particular clinical importance in patients with rapid consumption of platelets in the peripheral circulation as observed in DIC, acute immune thrombocytopenic purpura, or thrombotic thrombocytopenic purpura. Effective platelet production by bone marrow in these cases should be present with many large platelets in peripheral blood, many of which may not be identified by automated analyzers. An accurate platelet count can be obtained with a manual count using phase contrast microscopy.
After pseudothrombocytopenia appears, it usually remains indefinitely, 4,50 but in a few cases it is transient and disappears after some time. 4,59–63 A potential issue arises when subjects with pseudothrombocytopenia require surgical intervention under hypothermia, as occurs in heart surgery.
These highly dissimilar clinical situations confirm that pseudothrombocytopenia is not caused by or associated with a specific disease or the use of specific drugs, although occasional cases have been described in which pseudothrombocytopenia has appeared after the administration of valproic acid,44,45 olanzapine,46 insulin, 47 or levofloxacin. 48
It has been noted that in Glanzmann’s thrombasthenia, a disorder characterized by the quantitative and/or qualitative abnormality of GpIIb/IIIa, pseudothrombocytopenia does not occur. Interestingly, in recent years, abciximab (a GpIIb/IIIa antagonist) has been found to be associated with pseudothrombocytopenia [6].
It is noteworthy that on rare occasions pseudothrombocytopenia can be associated with chronic autoimmune thrombocytopenia, 4,51,73 in which case pseudothrombocytopenia artifactually further lowers the platelet count.